Can HPA-axis disruption and high cortisol produce a low-signaling thyroid state?

The interplay between the stress response (HPA axis) and thyroid function (HPT axis) is a well-documented physiological phenomenon. High levels of cortisol, whether from chronic stress, medical administration, or systemic illness, act as a powerful brake on thyroid signaling at every level of the axis.

Suppression of central thyroid drive

Research confirms that elevated cortisol levels directly suppress the two primary signals that tell the thyroid to work: Hypothalamic TRH and Pituitary TSH.

• Hypothalamic TRH: Glucocorticoids act as transcriptional repressors at the TRH promoter region in the hypothalamus. This reduces the synthesis and release of Thyrotropin-Releasing Hormone (TRH), the "master switch" for thyroid activity.
• Pituitary TSH: Cortisol inhibits the secretion of Thyroid-Stimulating Hormone (TSH) from the pituitary gland. In clinical studies, pharmacological doses of glucocorticoids can reduce serum TSH by 30-50% within hours. This inhibition is mediated by both direct action on pituitary cells and an increase in somatostatin, a hormone that naturally blocks TSH release.

Impairment of peripheral activation

Beyond central suppression, cortisol alters how the body processes thyroid hormones in the tissues, specifically the conversion of the pro-hormone T4 into the active hormone T3.

• Deiodinase modulation: Cortisol inhibits Type 1 deiodinase (D1), the enzyme responsible for most circulating T3. Concurrently, it can increase Type 3 deiodinase (D3), which converts T4 into inactive reverse T3 (rT3).
• Biochemical profile: This shift creates a "low-signaling" profile characterized by low or low-normal T3 levels and elevated rT3, even when TSH and T4 levels appear within standard laboratory reference ranges.

Mechanistic explanations

The molecular basis for this "low-signaling" picture involves the glucocorticoid receptor (GR) interacting with specific DNA elements. In the hypothalamus, the GR binds to the TRH gene to shut down production. In peripheral tissues like the liver, cortisol-induced shifts in enzymatic activity (D1 suppression and D3 induction) serve as a metabolic adaptation, likely designed to conserve energy during periods of high stress or illness.

Bottom line

HPA-axis disruption and elevated cortisol significantly suppress thyroid signaling by reducing central TRH/TSH output and impairing the peripheral conversion of T4 to active T3. For patients, this can result in clinical symptoms of hypothyroidism—such as fatigue and metabolic slowing—despite having a healthy thyroid gland and "normal" routine TSH tests.